A First-Class Degrader Candidate Targeting Both KRAS G12D and G12V Mediated by CANDDY Technology Independent of UbiquitinationEtsuko Miyamoto‐Sato, Masamichi Ishizaka|Molecules|2023Cited by 11
<i>In vivo</i> KRAS G12D/V degradation mediated by CANDDY using a modified proteasome inhibitorSatoshi Imanishi, Etsuko Miyamoto‐Sato|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 4